Share This Page
Drug Price Trends for NDC 42291-0498
✉ Email this page to a colleague
Average Pharmacy Cost for 42291-0498
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42291-0498
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| METFORMIN HCL 750MG 24HR TAB,SA | AvKare, LLC | 42291-0498-01 | 100 | 6.98 | 0.06980 | 2023-06-15 - 2028-06-14 | FSS |
| METFORMIN HCL 750MG 24HR TAB,SA | AvKare, LLC | 42291-0498-50 | 500 | 34.90 | 0.06980 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 42291-0498
Introduction
The drug identified by NDC 42291-0498 is a prescription pharmaceutical currently positioned in a specialized therapeutic niche. Analyzing its market landscape and projecting its pricing trajectory are essential for stakeholders, including pharmaceutical companies, investors, healthcare providers, and policy regulators. This report provides a detailed assessment of the current market conditions, competitive environment, regulatory factors, and price dynamics affecting NDC 42291-0498.
Product Profile and Therapeutic Positioning
NDC 42291-0498 corresponds to [specific drug name], indicated for [primary condition/indication]. Its formulation, dosing, and delivery system are tailored for [patient population], offering [notable advantages, e.g., improved efficacy, reduced side effects] relative to existing therapies. The drug's clinical profile aligns with targeted treatment protocols, supported by peer-reviewed studies highlighting its [efficacy/safety profile].
Market Landscape Overview
1. Market Size and Demographics
The therapeutic area associated with NDC 42291-0498 exhibits an estimated global market size of $X billion, driven predominantly by [major geographic regions]. In the United States, the segment encompasses approximately Y million patients, with an annual growth rate of Z% based on epidemiological data from [sources such as CDC, WHO]. The rising prevalence of [specific condition], along with increasing diagnostic rates, underscores a sustained demand trajectory.
2. Competitive Environment
The landscape features [number] approved drugs, with [name of primary competitors] occupying significant market share. Competition hinges on factors such as [price, efficacy, safety, administration route, patent status]. The innovator's patent protections—or the lack thereof—influence market exclusivity and generic entry timelines. [Note: Specific patent expiry dates, if available, impact future price and market potential.]
3. Regulatory Status and Approvals
NDC 42291-0498 is approved by the U.S. Food and Drug Administration (FDA), with patent protections valid until [date]. Ongoing or pending patent challenges might influence future market access and pricing strategies. The regulatory environment in emerging markets is evolving, with approvals in [list countries] expanding potential revenue streams.
Pricing Dynamics and Historical Trends
1. Current Price Points
The average wholesale price (AWP) for NDC 42291-0498 stands at approximately $X per unit/dose. Insurance reimbursement rates, Medicare Part D pricing, and pharmacy benefit management negotiations significantly influence actual transaction prices. Recent formulary placements indicate a [trend: e.g., upward, stable, or declining] price trajectory.
2. Factors Influencing Price Stability
- Patent Lifecycle: The patent protections afford temporary monopolistic pricing benefits, typically maintaining high prices. The impending patent expiry or patent challenges could precipitate price reductions.
- Market Exclusivity: Data exclusivity periods, especially in the case of biosimilars or biologics, affect pricing strategies.
- Demand and Utilization Patterns: Growing awareness and clinician adoption support sustained demand, often maintaining favorable pricing levels.
- Reimbursement Policies: Payer negotiations, prior authorization requirements, and coverage decisions directly impact net prices.
Projected Price Trajectory
Based on current trends, industry analyses, and patent considerations, the following projections apply:
| Year | Price Trend | Rationale |
|---|---|---|
| 2023–2024 | Slight decrease (~2–5%) | Anticipated patent horizon approaching, generic threat looming in some markets |
| 2025–2026 | Stabilization or minor reduction (~0–3%) | Market maturation, payer negotiations intensify |
| 2027 and beyond | Potential decline (~10–20%) upon patent expiry | Entry of biosimilars/generics, increased price competition |
Note: These projections assume no new formulation breakthroughs nor significant regulatory shifts.
Key Market Drivers and Risks
Drivers:
- Increased Disease Incidence: Rising prevalence of [disease] enhances demand.
- Regulatory Approvals: Expanded indications or approvals in additional markets broaden revenue potentials.
- Pipeline Advances: Ongoing clinical trials promising enhanced formulations could influence future pricing and market share.
Risks:
- Patent Expiry: Potential loss of exclusivity may trigger price erosion.
- Competitive Entry: Generics or biosimilars could significantly reduce prices.
- Pricing and Reimbursement Policies: Legislative measures targeting drug pricing might cap profits or lower prices.
- Market Saturation: High adoption rates may reach a plateau, stabilizing or decreasing prices.
Strategic Implications for Stakeholders
- Pharmaceutical Companies: Should monitor patent status closely, consider lifecycle extensions, and plan for biosimilar competition.
- Investors: Market entry dates for generics or biosimilars are critical milestones—affecting valuation and returns.
- Healthcare Providers: Pricing and formulary positioning influence prescribing patterns and access.
- Policy Makers: Regulatory reforms could impact pricing, access, and future market dynamics.
Conclusion
NDC 42291-0498 operates within a competitive, evolving landscape shaped by patent protections, emerging biosimilars, and demographic trends. Its current pricing sustains a lucrative but potentially volatile market position. Strategic planning by stakeholders must factor in patent expiry timelines, competitive pressures, and reimbursement dynamics to optimize market share and profitability over the coming decade.
Key Takeaways
- The drug's current price remains favorable due to patent protections and limited competition but faces imminent erosion upon patent expiration.
- Market growth is driven by increasing disease prevalence and expanding indications but is tempered by regulatory and competitive risks.
- Price projections suggest stability in the next 1-2 years, with potential declines starting mid-decade as biosimilars or generics enter the market.
- Stakeholders should monitor patent status, regulatory developments, and market uptake to inform investment, pricing, and access strategies.
- Diversification into emerging markets and indication expansion can mitigate revenue risks associated with patent cliffs.
FAQs
-
What is the primary therapeutic indication of NDC 42291-0498?
The drug is indicated for [specific condition e.g., rheumatoid arthritis, certain cancers, rare genetic diseases], targeting [patient demographics] to improve [clinical outcomes]. -
How does patent expiry affect the drug’s future price?
The expiration of patent protections typically opens the market to biosimilar or generic competition, leading to substantial price reductions—potentially up to 80% or more, depending on market conditions. -
Are biosimilars or generics available for NDC 42291-0498?
As of now, [status: e.g., biosimilars are in development, patents are active, or market exclusivity is still in effect], but imminent patent expiry indicates potential biosimilar entry within [timeline]. -
What are the key factors influencing the drug's pricing today?
Patent status, market exclusivity, clinical demand, reimbursement negotiations, and competitive landscape are primary determinants shaping current pricing. -
How can stakeholders prepare for upcoming market changes?
Continuous monitoring of patent lapses, engagement with payers for formulary positioning, investment in pipeline developments, and diversification strategies are crucial for resilience against price declines.
References
- [Insert relevant industry reports, FDA approval documents, market research studies, clinical trial data, or authoritative sources used in analysis.]
- [For example:] IQVIA (2022). Global Trends in Biologic Drug Pricing.
- [Additional sources linked to epidemiological data, regulatory updates, or patent filings.]
Note: All data points are hypothetical examples; actual data should be sourced from comprehensive market research and current industry reports for precise decision-making.
More… ↓
